Synergistic inhibition of colorectal cancer progression by silencing Aurora A and the targeting protein for Xklp2

doi:10.4240/wjgs.v17.i1.97148

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (654)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-5) series.

Item

Count

PDF

HTML

214

Figures (1-7)

Tables (1-5)

Sum=356

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

155

Sum=221

Publishing Process of This Article

Item

Count

Browse

Download

Sum=55

Jan 27, 2025 (publication date) through Feb 4, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Surg. Jan 27, 2025; 17(1): 97148
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.97148

Table 3 Antibody information

Antibody	Manufacturer	No.	Dilution ratio
AURKA antibody	Affinity	BF0123	1:2000
TPX2 antibody	Abcam	ab264124	1:5000
Cyclin B1 antibody	Affinity	AF6168	1:2000
CDK1 antibody	Abcam	ab133327	1:15000
CDK2 antibody	Affinity	AF6237	1:2000
Bax antibody	Abcam	ab182733	1:2000
Bcl-2 antibody	Affinity	AF6139	1:2000
Caspase-3 antibody	Proteintech	19677-1-AP	1:10000
p53 antibody	Affinity	AF0879	1:2000
N-cadherin antibody	Affinity	AF4039	1:2000
E-cadherin antibody	Proteintech	20874-1-AP	1:5000
Vimentin antibody	Zenbio	R22775	1:1000
p-AURKA antibody	Affinity	AF3011	1:2000
β-actin antibody	Proteintech	81115-1-RR	1:20000
Anti-rabbit IgG, HRP-linked antibody	CST	7074	1:10000

AURKA: Aurora kinase A; TPX2: Targeting protein for Xklp2; Bcl-2: B-cell lymphoma-2; Bax: B-cell lymphoma-2 associated X protein; p53: Tumor protein P53; p-AURKA: Phosphorylated Aurora kinase A; HRP: Horseradish peroxidase; CST: Cell signaling technology.

Citation: Sheng GX, Zhang YJ, Shang T. Synergistic inhibition of colorectal cancer progression by silencing Aurora A and the targeting protein for Xklp2. World J Gastrointest Surg 2025; 17(1): 97148
URL: https://www.wjgnet.com/1948-9366/full/v17/i1/97148.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.97148